|
Bortezomib USP Related Compoud J;(S)-Hydroxy Des(boric Acid) Bortezomib;N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide; N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-pyrazi
|
硼替佐米USP雜質J
|
289472-81-7
|
|
Domperidone EP Impurity B
|
多潘立酮EP雜質B
|
1346598-11-5
|
|
Quetiapine EP Impurity P;Quetiapine N-Ethyl Impurity;11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine hydrochloride
|
喹硫平雜質P
|
1011758-03-4
|
|
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide
|
替卡格雷疊氮物
|
378236-67-0
|
|
Rapamycin ;Sirolimus
|
雷帕霉素;西羅莫司
|
53123-88-9
|
|
Clindamycin 2,4-Diphosphate
|
克林霉素2,4-二磷酸
|
1309048-48-3
|
|
Succinic acid mono-(1-dimethylaminomethyl-2-{2-[2-(3-methoxy-phenyl)-vinyl]-phenoxy}-ethyl) ester
|
沙格雷酯雜質1
|
1659311-42-8
|
|
Glycyrrhizic Acid (Glycyrrhizin)
|
甘草酸
|
1405-86-3
|
|
Isopropyl 4-methylbenzenesulfonate; propan-2-yl 4-methylbenzenesulfonate; Benzenesulfonic acid, 4-methyl-, 1-methylethyl ester; Isopropyl p-toluenesulfonate; Isopropyl p-tosylate;
|
對甲苯磺酸異丙酯
|
2307-69-9
|
|
Rivaroxaban ImpIII
|
利伐沙班雜質III-脫氧化合物
|
1415566-28-7
|
|
ortho-Hydroxy Atorvastatin Calcium Salt
|
鄰羥基阿托伐他汀鈣鹽
|
265989-46-6
|
|
Rivaroxaban Diamine Impurity
|
利伐沙班二胺雜質
|
1807455-76-0
|
|
(2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol hydrochloride
|
利奈唑胺雜質17
|
333753-72-3
|
|
Baccatin III
|
巴卡丁 III
|
27548-93-2
|
|
Domperidone EP Impurity A
|
多潘立酮EP雜質A
|
53786-28-0
|
|
Dibenzo[b,f][1,4]thiazepin-11(10H)-one, 5-oxide
|
二苯并[b,f][1,4]硫氮雜卓-11-[10H]酮-5-氧化物
|
20290-48-6
|
|
Lansoprazole EP Impurity B ;Lansoprazole Sulfone
|
蘭索拉唑EP雜質B;蘭索拉唑砜
|
131926-99-3
|
|
Cefixime Impurity 1
|
頭孢克肟雜質1
|
80544-17-8
|
|
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one Hydrochloride; 6,7,8,9-Dehydro 9-Hydroxy Risperidone Hydrochloride
|
帕潘立酮棕櫚酸酯P3加氫不完全雜質
|
170359-61-2
|
|
2-[(2S)-3-Chloro-2-hydroxypropyl]-1H-isoindole-1,3(2H)-dione
|
利伐沙班雜質
|
148857-42-5
|
|
Quetiapine EP Impurity W;O-Dibenzo[b,f][1,4]thiazepinyl Quetiapine;11-(2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy) dibenzo[b,f][1,4]thiazepine
|
喹硫平EP雜質W
|
1800608-95-0
|
|
Rivaroxaban Triamine Impurity
|
利伐沙班三胺雜質
|
1632463-24-1
|
|
Linezolid Diphthalimide;2,2'-(3,3'-(3-Fluoro-4-morpholinophenylazanediyl)bis(2-hydroxypropane-3,1-diyl))diidoindoline-1,3-dione
|
利奈唑胺雜質16
|
1798014-14-8
|
|
3-methyl-4,5-diphenylisoxazole
|
帕瑞昔布雜質I
|
75115-00-3
|
|
1,1,2-Triethoxy-ethane
|
乙氧基乙醛二乙基乙縮醛
|
4819-77-6
|
|
3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
|
帕潘立酮棕櫚酸酯開環(huán)雜質
|
152542-03-5
|
|
Olmesartan Acid
|
奧美沙坦酸
|
144689-24-7
|
|
Meloxicam Related Compound A
|
美洛昔康相關化合物A
|
24683-26-9
|
|
Glycopyrronium impurity M
|
格隆溴銨雜質M
|
5422-88-8
|
|
2-hydroxy-cinchoninic Acid; 1,2-Dihydro-2-oxo-4-Cinchocaine EP Impurity B;quinolinecarboxylic Acid; 2-Hydroxy-4-quinolinecarboxylic Acid; 2-Hydroxycinchoninic Acid; 2-Hydroxyquinoline-4-carboxylic Acid; 4-Carboxycarbostyril;
|
辛可卡因雜質B
|
15733-89-8
|
|
Olmesartan Medoxomil EP Impurity C
|
奧美沙坦酯雜質C
|
879562-26-2
|
|
Bortezomib USP Related Compoud I;(R)-Hydroxy Des(boric Acid) Bortezomib;N-[(1S)-2-[[(1R)-1-Hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide; N-[(1S)-2-[[(1R)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]pyrazin
|
硼替佐米USP雜質I
|
289472-78-2
|
|
Dasatinib Dimeric Impurity;2,2'-[1,4-Piperazinediylbis[(2-methyl-6,4-pyrimidinediyl)imino]]bis[N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide
|
達沙替尼二聚體雜質2
|
910297-61-9
|
|
Lansoprazole EP Impurity C
|
蘭索拉唑EP雜質C
|
103577-40-8
|
|
Donepezil Deoxy Impurity
|
多奈哌齊脫氧雜質
|
844694-84-4
|
|
Cinchocaine EP Impurity C ;Dibucaine Impurity C)
|
辛可卡因EP雜質C;地布卡因雜質C
|
87864-08-2
|
|
(S)-3-phenyl-2-(pyrazine-2-carboxamido)propanoic acid
|
硼替佐米USP雜質D
|
114457-94-2
|
|
Donepezil Benzyl Bromide Impurity
|
鹽酸多奈哌齊芐基溴
|
844694-85-5
|
|
Cinchocaine EP Impurity D;2-Butoxy-4-quinolinecarboxylic Acid; 2-Butoxy-cinchoninic Acid
|
辛可卡因雜質D
|
10222-61-4
|
|
Bortezomib USP Related Compoud M;(S)-Hydroperoxy Des(boric Acid) Bortezomib;N-((S)-1-(((S)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
|
硼替佐米USP雜質M
|
886979-81-3
|
|
para-Hydroxy Atorvastatin Calcium Salt
|
對羥基阿托伐他汀鈣鹽
|
265989-44-4
|
|
Doxofylline Impurity 2
|
多索茶堿雜質2
|
5614-53-9
|
|
(S)-N-(3-chloro-2-hydroxy-1-propyl)acetamide
|
利奈唑胺雜質19
|
224323-47-1
|
|
N-[(1-Methyl-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester formate
|
達比加群酯雜質CDBA468
|
|
|
Omeprazole Impurity H215/01
|
奧美拉唑雜質H215 /01
|
301669-82-9
|
|
Acetic propionic anhydride;acetyl propanoate
|
乙酸丙酸酐
|
13080-96-1
|
|
Donepezil Dehydrodeoxy Impurity
|
多奈哌齊脫氫脫氧雜質
|
120013-45-8
|
|
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-7,8-dihydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione
|
帕潘立酮棕櫚酸酯氧化雜質
|
1189516-65-1
|
|
Domperidone Impurity C
|
多潘立酮雜質C
|
118435-03-3
|
|
Domperidone EP Impurity E
|
多潘立酮EP雜質E
|
1346602-50-3
|
|
Irbesartan Impurity 7
|
厄貝沙坦雜質7
|
141745-71-3
|
|
Meloxicam Related Compound B
|
美洛昔康相關化合物B
|
7305-71-7
|
|
Rabeprazole EP Impurity D
|
雷貝拉唑EP雜質D
|
924663-38-7
|
|
Omeprazole Related Compound 6
|
奧美拉唑相關化合物6
|
86604-80-0
|
|
Rabeprazole Impurity C
|
雷貝拉唑雜質C
|
168167-42-8
|
|
Rebeprazole sulfone N-oxide
|
Rabeprazole EP Impurity I(灰色)
|
924663-37-6
|
|
9-[(2S)-2-(diethoxyphosphorylmethoxy)propyl]purin-6-amine
|
替諾福韋二乙酯
|
180587-75-1
|
|
Rabeprazole Related Compound A
|
雷貝拉唑相關化合物A
|
1163685-30-0
|
|
Lansoprazole EP Impurity A ;Lansoprazole N-Oxide
|
蘭索拉唑EP雜質A;蘭索拉唑N-氧化物
|
213476-12-1
|
|
Bortezomib USP Related Compoud H;(1R,2R)-Bortezomib;B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
|
硼替佐米USP雜質H
|
1132709-15-9
|
|
Bortezomib USP Related Compoud B;N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
|
硼替佐米USP雜質B
|
289472-80-6
|
|
Dabigatran etexilate Impurity F
|
達比加群酯雜質F
|
1702936-92-2
|
|
N-Butyryl-4-(5-methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
|
帕瑞昔布鈉雜質D
|
198470-92-7
|
|
(R)-3-methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butylboronic acid
|
硼替佐米USP雜質O
|
1194235-41-0
|
|
(3R,4R,5R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol
|
達格列凈呋喃環(huán)雜質
|
1469910-83-5
|
|
Doxofylline Impurity 1
|
多索茶堿雜質1
|
1429636-74-7
|
|
Clopidogrel Related Compound A ;(S)-Clopidogrel Carboxylic Acid
|
氯吡格雷相關化合物A;(S)- 氯吡格雷羧酸
|
144457-28-3
|
|
Ibuprofen EP Impurity K
|
布洛芬EP雜質K
|
43153-07-7
|
|
Rabeprazole Sulfide
|
雷貝拉唑硫化物
|
117977-21-6
|
|
Quetiapine EP Impurity H;2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol N-oxide
|
喹硫平雜質H
|
1076199-40-0
|
|
2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol; Quetiapine EP Impurity I;
|
喹硫平雜質I
|
329216-67-3
|
|
ethyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate
|
替卡格雷化合物D
|
1006376-61-9
|
|
Fludarabine Phosphate EP Impurity B
|
氟達拉濱磷酸鹽EP雜質B
|
149297-79-0
|
|
Bortezomib USP Related Compoud L;(R)-Hydroperoxy Des(boric Acid) Bortezomib;N-((S)-1-(((R)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
|
硼替佐米USP雜質L
|
886979-78-8
|
|
Rivaroxaban Impurity 1
|
利伐沙班雜質1
|
721401-53-2
|
|
Rivaroxaban ImpIV
|
利伐沙班雜質IV
|
1770812-37-7
|
|
4-methylbenzenesulfonamide; p-Toluenesulfonamide;
|
對甲苯磺酰胺
|
70-55-3
|
|
Desbenzyl Donepezil;2,3-Dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-1H-inden-1-one; 4-[(5,6-Dimethoxy-1-oxoindan-2-yl)methyl]piperidine; 5,6-Dimethoxy-2-[(4-piperidinyl)methyl]-1-indanone;
|
脫芐多奈哌齊
|
120014-30-4
|
|
Meloxicam Impurity E
|
美洛昔康雜質E
|
35511-15-0
|
|
brevifolin carboxylic acid;brevifolincarboxylic acid
|
短葉蘇木酚酸
|
18490-95-4
|
|
11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine; Quetiapine EP Impurity D;Quetiapine Dimer Impurity
|
喹硫平雜質D
|
945668-94-0
|
|
5-[2-[5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbonyl]oxypropan-2-yl]-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid
|
奧美沙坦酯二聚體雜質
|
1040250-19-8
|
|
2-{2-[2-(3-Methoxy-phenyl)-ethyl]-phenoxymethyl}-oxirane
|
沙格雷酯雜質2
|
1140968-46-2
|
|
Citalopram Dimethylaminobutanone Di-Oxalate ;5-Dimethylaminobutyryl Citalopram Di-Oxalate
|
西酞普蘭二甲氨基丁酮迪草酸鹽;5-二甲基氨基丁?；魈仗m二草酸酯
|
|
|
Betahistine EP Impurity C TriHCl
|
鹽酸倍他司汀EP雜質C
|
|
|
Glycopyrronium impurity K
|
格隆溴銨雜質K
|
3900-93-4
|
|
N-[3-chloro-2-(R)-hydroxypropyl]-3-fluoro-4-(morpholin-4-yl)aniline
|
利奈唑胺雜質8
|
868405-66-7
|
|
Rabeprazole EP Impurity E
|
雷貝拉唑EP雜質E
|
102804-77-3
|
|
Rivaroxaban ImpVI
|
利伐沙班雜質VI
|
446292-08-6
|
|
Omeprazole EP Impurity B
|
奧美拉唑EP雜質B
|
110374-16-8
|
|
Fludarabine Phosphate EP Impurity F
|
氟達拉濱磷酸鹽EP雜質F
|
159002-28-5
|
|
Hydroxy Donepezi;2,3-Dihydro-2-[hydroxy[1-(phenylmethyl)-4-piperidinyl]methyl]-5,6-dimethoxy-1H-inden-1-one; 2-[(1-Benzylpiperidin-4-yl)hydroxymethyl]-5,6-dimethoxyindan-1-one;
|
多奈哌齊羥基雜質
|
197010-20-1
|
|
Glycopyrronium impurity H
|
格隆溴銨雜質H
|
15206-55-0
|
|
Domperidone EP Impurity F
|
多潘立酮EP雜質F
|
1391053-55-6
|
|
Sitagliptin Deamino Impurity 2 (Mixture of Z and E Isomers);3-Desamino-3,4-dehydro Sitagliptin;(E)-1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one
|
西格列汀FP雜質C
|
1675201-14-5
|
|
(2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol 2-Acetate; (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol Acetate (Ester)
|
利奈唑胺雜質7
|
|
|
Tacrolimus
|
他克莫司
|
104987-11-3
|